Perioperative systemic treatments in renal cell carcinoma

被引：3
|
作者：
Goswamy, Rohit [1 ,2 ]
Kalemoglu, Ecem [3 ]
Master, Viraj [2 ,4 ]
Bilen, Mehmet Asim [1 ,2 ]
机构：
[1] Emory Univ, Sch Med, Dept Hematol & Med Oncol, Atlanta, GA 30322 USA
[2] Emory Univ, Winship Canc Inst, Dept Hematol & Med Oncol, Atlanta, GA 30322 USA
[3] Emory Univ, Sch Med, Dept Biochem, Atlanta, GA USA
[4] Emory Univ, Sch Med, Dept Urol, Atlanta, GA 30322 USA
来源：
FRONTIERS IN ONCOLOGY | 2024年 / 14卷
关键词：
renal cell carcinoma; neoadjuvant; adjuvant; kidney cancer; review; cancer; RCC (Renal Cell Carcinoma); outcomes; NIVOLUMAB PLUS CABOZANTINIB; HIGH-RISK; INTERFERON-ALPHA; PHASE-III; FOLLOW-UP; NEOADJUVANT AXITINIB; SURGICAL-MANAGEMENT; ADJUVANT PAZOPANIB; SURVIVAL ANALYSIS; DOUBLE-BLIND;
D O I：
10.3389/fonc.2024.1362172
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
In this review, we aim to provide a comprehensive assessment of the evolving landscape of the perioperative management in renal cell carcinoma (RCC), emphasizing its dynamic and intricate nature. We explore academic and clinical insights into the perioperative treatment paradigm of RCC. Up-to-date treatment options are discussed and the evolving role of neoadjuvant and adjuvant therapy in RCC is highlighted.
引用
收藏
页数：15
相关论文
共 50 条
  • [21] Role of perioperative immunotherapy in localized renal cell carcinoma
    Kaur, Jasmeet
    Patil, Goutham
    Geynisman, Daniel M.
    Ghatalia, Pooja
    THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 2023, 15
  • [22] Topical and systemic medical treatments of basal cell carcinoma
    Sollena, P.
    Del Regno, L.
    Fargnoli, M. C.
    Peris, K.
    GIORNALE ITALIANO DI DERMATOLOGIA E VENEREOLOGIA, 2015, 150 (04): : 429 - 434
  • [23] Management of bone metastases in renal cell carcinoma: bone-targeted treatments, systemic therapies, and radiotherapy
    Mansinho, Andre
    Nejo, Priscila
    Leitao, Tito
    Casimiro, Sandra
    Costa, Luis
    JOURNAL OF CANCER METASTASIS AND TREATMENT, 2021, 7
  • [24] Predictive factors for response to systemic treatments carried out in patients with advanced renal cell carcinoma.
    Muriel, C.
    Esteban, E.
    Martinez-Camblor, P.
    Astudillo, A.
    Crespo, G.
    Pardo, P.
    Izquierdo, M.
    Berros, J. P.
    Gutierrez, E.
    Lacave, A. J.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [25] Systemic Treatments for Metastatic Renal Cell Carcinoma: 10-Year Experience of Immunotherapy and Targeted Therapy
    Kim, Sung Han
    Park, Weon Seo
    Kim, Sun Ho
    Joung, Jae Young
    Seo, Ho Kyung
    Lee, Kang Hyun
    Chung, Jinsoo
    CANCER RESEARCH AND TREATMENT, 2016, 48 (03): : 1092 - 1101
  • [26] Systemic Therapy for Metastatic Renal Cell Carcinoma
    Kramer, M. W.
    Steffens, S.
    von Klot, C.
    Merseburger, A. S.
    Kuczyk, M. A.
    AKTUELLE UROLOGIE, 2012, 43 (04) : 265 - 268
  • [27] Systemic therapy for sarcomatoid renal cell carcinoma
    Pagliaro, Lance C.
    Tannir, Nizar
    Sircar, Kanishka
    Jonasch, Eric
    EXPERT REVIEW OF ANTICANCER THERAPY, 2011, 11 (06) : 913 - 920
  • [28] Systemic therapy of metastasizing renal cell carcinoma
    Staehler, M.
    Haseke, N.
    Zilinberg, K.
    Stadler, T.
    Karl, A.
    Stief, C. G.
    UROLOGE, 2008, 47 (10): : 1357 - 1365
  • [29] Systemic therapy of metastatic renal cell carcinoma
    Maute, L.
    Bergmann, L.
    ONKOLOGE, 2015, 21 (01): : 35 - +
  • [30] Systemic Therapy for Metastatic Renal Cell Carcinoma
    Kroog, Glenn S.
    Motzer, Robert J.
    UROLOGIC CLINICS OF NORTH AMERICA, 2008, 35 (04) : 687 - 701
12345